Todd J. Sullivan, Ph.D.

Affiliations: 
2005 Stony Brook University, Stony Brook, NY, United States 
Google:
"Todd Sullivan"
Mean distance: 2949.11
 

Parents

Sign in to add mentor
Peter J. Tonge grad student 2005 SUNY Stony Brook
 (Developing novel inhibitors of the enoyl reductase from Mycobacterium tuberculosis (InhA): SAR studies of triclosan congeners.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sharma H, Landau MJ, Sullivan TJ, et al. (2014) Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase. Bioorganic & Medicinal Chemistry Letters. 24: 1232-5
Iyidogan P, Sullivan TJ, Chordia MD, et al. (2013) Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase. Acs Medicinal Chemistry Letters. 4: 1183-8
Bailey CM, Sullivan TJ, Iyidogan P, et al. (2013) Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategy. Journal of Medicinal Chemistry. 56: 3959-68
Younis Y, Hunter R, Muhanji CI, et al. (2010) [d4U]-spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase. Bioorganic & Medicinal Chemistry. 18: 4661-73
England K, am Ende C, Lu H, et al. (2009) Substituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemia. The Journal of Antimicrobial Chemotherapy. 64: 1052-61
am Ende CW, Knudson SE, Liu N, et al. (2008) Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 3029-33
Xu H, Sullivan TJ, Sekiguchi J, et al. (2008) Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus. Biochemistry. 47: 4228-36
Boyne ME, Sullivan TJ, amEnde CW, et al. (2007) Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors. Antimicrobial Agents and Chemotherapy. 51: 3562-7
Sullivan TJ, Truglio JJ, Boyne ME, et al. (2006) High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis. Acs Chemical Biology. 1: 43-53
Sivaraman S, Sullivan TJ, Johnson F, et al. (2004) Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues. Journal of Medicinal Chemistry. 47: 509-18
See more...